Analyst Price Targets — VALN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 16, 2026 10:48 am | — | Guggenheim | $11.00 | $6.03 | TheFly | Valneva price target lowered to $11 from $13 at Guggenheim |
| August 25, 2025 2:58 pm | Maury Raycroft | Jefferies | $14.00 | $9.43 | TheFly | Valneva price target lowered to $14 from $18 at Jefferies |
| March 24, 2025 11:28 am | Vamil Divan | Guggenheim | $15.00 | $7.43 | TheFly | Valneva price target lowered to $15 from $17 at Guggenheim |
| July 1, 2024 6:40 am | Edward White | H.C. Wainwright | $26.00 | $7.39 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Valneva SE (VALN) |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for VALN

Valneva SE (VALN) Shareholder/Analyst Call Prepared Remarks Transcript

Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that shareholders approved all resolutions recommended by the Board of Directors at the Company's Annual General Meeting (AGM), held earlier today in Lyon, France. Key resolutions adopted included the approval of the 2025…

Lyon (France), June 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Annual General Meeting (“the Meeting”) to be held on June 25, 2026 at 2:00 p.m. CEST at the Sofitel Lyon Bellecour Hotel, 20 quai du Docteur Gailleton, 69002 Lyon (France).

Lyon (France), May 28, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor conferences in the United States and Europe in June 2026.

Lyon (France), May 28, 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor conferences in the United States and Europe in June 2026.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for VALN.
Senate Trading
No Senate trades found for VALN.
U.S. House Trading
No House trades found for VALN.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
